301258SZSE

Verification Opinion from Dongfang Securities Co., Ltd. on the Securities and Derivatives Investment Situation of Suzhou Fushilai Pharmaceutical Co., Ltd. for the Year 2025

Fujilai Co., Ltd.·

Full Translation

Notes & Comments

Sign in to leave a comment or private note.

Loading…

Verification Opinion from Dongfang Securities Co., Ltd. on the Securities and Derivatives Investment Situation of Suzhou Fushilai Pharmaceutical Co., Ltd. for the Year 2025 — Fujilai Co., Ltd. | SZSE Releases